A comprehensive view of novavax inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to Novavax on Jan. 3 for "Coronavirus vaccine formulations" (Maryland Inventors)
Published: January 21, 2023 by U.S. Fed News
Patent Issued for Coronavirus vaccine formulations (USPTO 11541112)
Published: January 20, 2023 by NewsRx COVID-19 Daily
Novavax Nuvaxovid COVID-19 vaccine approved in South Korea as an adult booster; the vaccine is authorized for use as an adult booster in more than 35 countries, with other countries recommending use of the vaccine as a booster dose
Published: January 18, 2023 by PR Newswire
Health Canada grants Novavax’s COVID-19 vaccine booster expanded authorization for use in adults aged 18 and older
Published: January 17, 2023 by Indian Pharma Industry: Policies
Intellectual Property India Publishes Patent Application for 'Coronavirus Vaccine Formulations' Filed by Novavax, Inc.
Published: January 14, 2023 by India Government News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count